Over 84 weeks in 809 patients, CagriSema delivered 23% mean weight loss versus 25.5% for tirzepatide
By reducing body weight, improving insulin sensitivity, lowering inflammatory markers, and addressing metabolic dysfunction, they target the very factors that make Hashimoto's management so challenging
Animal studies showed retatrutide producing lower expression levels of inflammatory and fibrotic mediators compared to tirzepatide, suggesting the triple mechanism may offer benefits beyond additional weight loss
The final shape continues to refine for up to one year post-operatively
To enhance optimum GLP-1 secretion and kickstart your day, try a veggie omelet or a couple of cooked eggs
These data anchor the exercise-mimetic label in mechanistic and phenotypic readouts encompassing gene expression, mitochondrial content, fiber identity, and performance